Related Experiment Videos
Morbidity with contemporary prostate biopsy
P M Desmond1, J Clark, I M Thompson
1Urology Service, Brooke Army Medical Center, San Antonio, Texas.
Abstract:
To determine the incidence of complications associated with contemporary prostate biopsy, a review of 670 men undergoing transrectal prostate biopsy using 18 gauge biopsy needles was conducted. Of the men 580 received 1 to 3 days of ciprofloxacin antibiotic prophylaxis. A total of 16 patients (2.1%) suffered complications of whom 4 (0.6%) required hospitalization. These data demonstrate the low morbidity associated with contemporary transrectal prostate biopsy.
Insights
Contemporary transrectal prostate biopsy has low complication rates. This study of 670 men found only 2.1% experienced complications, with 0.6% requiring hospitalization, highlighting the procedure's safety.
Area of Science:
- Urology
- Surgical Oncology
- Medical Informatics
Background:
- Prostate biopsy is a critical diagnostic tool.
- Assessing complication incidence is vital for patient care.
- Transrectal prostate biopsy is a common procedure.
Purpose of the Study:
- To evaluate the incidence of complications from contemporary transrectal prostate biopsy.
- To assess the safety profile of 18-gauge needle biopsies.
- To quantify the need for hospitalization due to biopsy complications.
Main Methods:
- Retrospective review of 670 men undergoing transrectal prostate biopsy.
- Utilized 18-gauge biopsy needles.
- Analyzed complication rates, including those requiring hospitalization, in patients receiving antibiotic prophylaxis.
Main Results:
- A total of 16 patients (2.1%) experienced complications.
- Four patients (0.6%) required hospitalization.
- The majority of patients tolerated the procedure with minimal adverse events.
Conclusions:
- Contemporary transrectal prostate biopsy demonstrates low morbidity.
- The procedure is generally safe with a low risk of significant complications.
- Antibiotic prophylaxis appears effective in minimizing adverse outcomes.